Teva to Present at the UBS Global Specialty Pharmaceuticals Conference

JERUSALEM--(BUSINESS WIRE)-- Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) will host a live audio webcast at the UBS Global Specialty Pharmaceuticals Conference with Eyal Desheh, Teva's Chief Financial Officer, presenting on Wednesday, June 2, 2010 in London.

What: Teva's Presentation at the UBS Global Specialty Pharmaceuticals Conference

Who: Eyal Desheh, Chief Financial Officer, Teva Pharmaceutical Industries Ltd.

When: Wednesday, June 2, 2010 at 10:30 AM (local UK time)

Where: or

How: Live over the Internet -- log on to the Web at the address above and register for the event (approx. 10 minutes before). An archive of the webcast will be available on Teva's website.

About Teva

Teva Pharmaceutical Industries Ltd., headquartered in Israel, is among the top 15 pharmaceutical companies in the world and is the leading generic pharmaceutical company. The company develops, manufactures and markets generic and innovative pharmaceuticals and active pharmaceutical ingredients. Over 80 percent of Teva's sales are in North America and Western Europe.


Teva Pharmaceutical Industries Ltd.
Elana Holzman, 972 (3) 926-7554
Teva North America
Kevin Mannix, 215-591-8912

KEYWORDS:   Middle East  Israel

INDUSTRY KEYWORDS:   Health  Pharmaceutical